Because of a lack of better treatments...Question?
Why keytruda that has a a very low 18%CR and many serious side effects, was accepted by the FDA for Bladder Cancer patients.
In this article dated Jan.10, 2020..
https://gr-cis.com/2020/01/10/mercks-keytruda-approved-for-high-risk-bladder-cancer/ .
Paragraph 5,
Merck said" Keytruda will be a new clinical option for a patients population that previously had limited FDA- Approved therapies available".
Can you believe this... Keytruda with its very low CR% and serious side effects was approved by the FDA for Bladder cancer, because of a lack of better treatments.
TLT time is coming.